A direct and continuous assay for the determination of thioredoxin reductase activity in cell lysates

被引:24
作者
Cunniff, Brian [1 ]
Snider, Gregg W. [2 ]
Fredette, Nicholas [1 ]
Hondal, Robert J. [2 ]
Heintz, Nicholas H. [1 ]
机构
[1] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA
[2] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA
基金
美国国家卫生研究院;
关键词
Thioredoxin reductase; Assay; Redox homeostasis; SELENOCYSTEINE; GLUTATHIONE; ACROLEIN; SYSTEM;
D O I
10.1016/j.ab.2013.08.013
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Thioredoxin reductase (TR) is an oxidoreductase responsible for maintaining thioredoxin in the reduced state, thereby contributing to proper cellular redox homeostasis. The C-terminal active site of mammalian TR contains the rare amino acid selenocysteine, which is essential to its activity. Alterations in TR activity due to changes in cellular redox homeostasis are found in clinical conditions such as cancer, viral infection, and various inflammatory processes; therefore, quantification of thioredoxin activity can be a valuable indicator of clinical conditions. Here we describe a new direct assay, termed the SC-TR assay, to determine the activity of TR based on the reduction of selenocystine, a diselenide-bridged amino acid. Rather than being an end-point assay as in older methods, the SC-TR assay directly monitors the continuous consumption of NADPH at 340 nm by TR as it reduces selenocystine. The SC-TR assay can be used in a cuvette using traditional spectrophotometry or as a 96-well plate-based format using a plate reader. In addition, the SC-TR assay is compatible with the use of nonionic detergents, making it more versatile than other methods using cell lysates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 24 条
[1]  
Arner E.S., 2001, CURR PROTOC TOXICOL
[2]  
Arner ESJ, 1999, METHOD ENZYMOL, V300, P226
[3]   Thioredoxin, a redox enzyme released in infection and inflammation, is a unique chemoattractant for neutrophils, monocytes, and T cells [J].
Bertini, R ;
Howard, OMZ ;
Dong, HF ;
Oppenheim, JJ ;
Bizzarri, C ;
Sergi, R ;
Caselli, G ;
Pagliei, S ;
Romines, B ;
Wilshire, JA ;
Mengozzi, M ;
Nakamura, H ;
Yodoi, J ;
Pekkari, K ;
Gurunath, R ;
Holmgren, A ;
Herzenberg, LA ;
Herzenberg, LA ;
Ghezzi, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (11) :1783-1789
[4]   Reduction of lipoic acid by lipoamide dehydrogenase [J].
Biewenga, GP ;
Dorstijn, MA ;
Verhagen, JV ;
Haenen, GRMM ;
Bast, A .
BIOCHEMICAL PHARMACOLOGY, 1996, 51 (03) :233-238
[5]  
Bjornstedt M, 1997, BIOMED ENVIRON SCI, V10, P271
[6]   SELENOCYSTEINE - THE 21ST AMINO-ACID [J].
BOCK, A ;
FORCHHAMMER, K ;
HEIDER, J ;
LEINFELDER, W ;
SAWERS, G ;
VEPREK, B ;
ZINONI, F .
MOLECULAR MICROBIOLOGY, 1991, 5 (03) :515-520
[7]   IDENTIFICATION AND QUANTITATION OF GLUTATHIONE IN HEPATIC PROTEIN MIXED DISULFIDES AND ITS RELATIONSHIP TO GLUTATHIONE DISULFIDE [J].
BRIGELIUS, R ;
MUCKEL, C ;
AKERBOOM, TPM ;
SIES, H .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (17) :2529-2534
[8]   Thioredoxin: friend or foe in human disease? [J].
Burke-Gaffney, A ;
Callister, MEJ ;
Nakamura, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2005, 26 (08) :398-404
[9]   Regulation of cancer cell metabolism [J].
Cairns, Rob A. ;
Harris, Isaac S. ;
Mak, Tak W. .
NATURE REVIEWS CANCER, 2011, 11 (02) :85-95
[10]   Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene [J].
Gladyshev, VN ;
Jeang, KT ;
Stadtman, TC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (12) :6146-6151